Clinical Topics & News
News
FDA expands rimegepant indication to include migraine prevention
Rimegepant is currently the only migraine medication approved to both treat acute migraine attacks and help prevent future migraine attacks.
Clinical Topics & News
Medication overuse headache: Preventive treatment with or without detoxification?
Clinical Topics & News
Headache on the Hill goes virtual
Clinical Topics & News
Acute care of migraine and cluster headaches: Mainstay treatments and emerging strategies
Clinical Topics & News
Headache and COVID-19: Key questions answered
Clinical Topics & News
Migraine: Helping patients through a difficult journey
News
Physicians react: Doctors worry about patients reading their clinical notes
As part of the 21st Century Cures Act, patients will now have the right to see their medical notes.
News
Migraine nerve stimulation device now available over the counter
The device stimulates the trigeminal nerve using a reusable self-adhesive electrode placed on the forehead.
News
Positive phase 3 top-line results for migraine prevention drug
Atogepant 10, 30, and 60 mg, were associated with a significant reduction from baseline in mean monthly migraine days compared with placebo.
Clinical Topics & News
Expert outlines strategies for managing migraine in women
Dr. Susan Hutchinson discusses how to make informed treatment choices based on the life stage of the woman with migraine.